Pharmaceutical

AstraZeneca champions early kidney disease diagnosis with modelling data

Early diagnosis of chronic kidney disease has both economic and environmental benefits, according to AstraZeneca’s Mina Makar.

Jun 12, 2024 - 04:00
AstraZeneca champions early kidney disease diagnosis with modelling data
Early diagnosis of chronic kidney disease has both economic and environmental benefits, according to AstraZeneca’s Mina Makar.
Read the original article

Tags:

Previous Article

How do supermassive black holes get super massive?

Next Article

Tacalyx extends seed funding round to raise over €14m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Grünenthal gains Valinor Pharma and constipation drug Movantik

Grünenthal gains Valinor Pharma and constipation drug M...

Jul 24, 2024

STAT+: RaDonda Vaught, former Vanderbilt nurse who accidentally killed patient, says hospital issues contributed, too

STAT+: RaDonda Vaught, former Vanderbilt nurse who acci...

Mar 13, 2024

Biogen receives EMA CHMP recommendation for ALS drug Qalsody

Biogen receives EMA CHMP recommendation for ALS drug Qa...

Feb 26, 2024